Ypsomed Holding AG YPSN-Financial and Strategic SWOT Analysis Review

Ypsomed Holding AG YPSN-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDME2603FSA
  • |
  • Pages: 45
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Ypsomed Holding AG (YPSN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ypsomed Holding AG (Ypsomed) is a medical device company. It designs, develops and manufactures injection systems. Its offers pen injectors, autoinjectors, dual chamber pens and other custom products. The company also offers contract manufacturing, industrial design, human factors engineering and IP landscape management; final assembly infrastructure and registration. Ypsomed offers its solutions to physicians, pharmaceutical and biotech companies. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through its subsidiaries and distributors. Ypsomed operates along with its subsidiaries in America's Europe and Asia. Ypsomed is headquartered in Burgdorf, Switzerland.

Ypsomed Holding AG Key Recent Developments

May 20, 2016: Ypsomed business year 2015/16: Expectations exceeded

Jul 27, 2015: Ypsomed signs master agreement for range of injection systems

Apr 24, 2015: Ypsomed to increase production capacity

Mar 24, 2015: New Chief Operating Officer in the Ypsomed Group

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Ypsomed Holding AG-Key Facts 6

Ypsomed Holding AG-Key Employees 7

Ypsomed Holding AG-Key Employee Biographies 8

Ypsomed Holding AG-Major Products and Services 9

Ypsomed Holding AG-Medical Equipment Pipeline Products Data 11

Ypsomed Holding AG Pipeline Products by Equipment Type 11

Ypsomed Holding AG Pipeline Products by Development Stage 12

Ypsomed Holding AG-History 13

Ypsomed Holding AG-Company Statement 16

Ypsomed Holding AG-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 20

Ypsomed Holding AG-Business Description 20

Ypsomed Holding AG-Corporate Strategy 21

Ypsomed Holding AG-SWOT Analysis 22

SWOT Analysis-Overview 22

Ypsomed Holding AG-Strengths 22

Strength-Improved Performance of Delivery Devices Segment 22

Strength-Improved Liquidity 22

Strength-Research and Development 22

Ypsomed Holding AG-Weaknesses 23

Weakness-Product Safety Concerns 23

Weakness-Increasing Trade Receivables 23

Ypsomed Holding AG-Opportunities 24

Opportunity-Growing Diabetes Care Devices Market 24

Opportunity-Global Drug Delivery Devices Market 24

Opportunity-Strategic Initiatives 24

Ypsomed Holding AG-Threats 25

Threat-Rapid Technological Changes 25

Threat-Stringent Regulatory Environment 25

Threat-Stiff Competition 25

Ypsomed Holding AG-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

Ypsomed Holding AG, Medical Equipment, Deals By Year, 2010 to YTD 2016 33

Ypsomed Holding AG, Medical Equipment, Deals By Type, 2010 to YTD 2016 34

Ypsomed Holding AG, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

May 20, 2016: Ypsomed business year 2015/16: Expectations exceeded 36

Jul 27, 2015: Ypsomed signs master agreement for range of injection systems 38

Apr 24, 2015: Ypsomed to increase production capacity 39

Mar 24, 2015: New Chief Operating Officer in the Ypsomed Group 40

Section 6-Appendix 41

Methodology 41

Ratio Definitions 41

About GlobalData 45

Contact Us 45

Disclaimer 45

List of Figures

Ypsomed Holding AG Pipeline Products by Equipment Type 11

Ypsomed Holding AG Pipeline Products by Development Stage 12

Ypsomed Holding AG, Performance Chart (2012-2016) 30

Ypsomed Holding AG, Ratio Charts 32

Ypsomed Holding AG, Medical Equipment, Deals By Year, 2010 to YTD 2016 33

Ypsomed Holding AG, Medical Equipment, Deals by Type, 2010 to YTD 2016 34

List of Tables

Ypsomed Holding AG, Key Facts 6

Ypsomed Holding AG, Key Employees 7

Ypsomed Holding AG, Key Employee Biographies 8

Ypsomed Holding AG, Major Products and Services 9

Ypsomed Holding AG Number of Pipeline Products by Equipment Type 11

Ypsomed Holding AG Pipeline Products by Equipment Type 11

Ypsomed Holding AG Number of Pipeline Products by Development Stage 12

Ypsomed Holding AG Pipeline Products by Development Stage 12

Ypsomed Holding AG, History 13

Ypsomed Holding AG, Other Locations 17

Ypsomed Holding AG, Subsidiaries 17

Ypsomed Holding AG, Key Competitors 26

Ypsomed Holding AG, Ratios based on current share price 27

Ypsomed Holding AG, Annual Ratios 28

Ypsomed Holding AG, Interim Ratios 31

Ypsomed Holding AG, Medical Equipment, Deals By Year, 2010 to YTD 2016 33

Ypsomed Holding AG, Medical Equipment, Deals By Type, 2010 to YTD 2016 34

Ypsomed Holding AG, Recent Deals Summary 35

Currency Codes 41

Capital Market Ratios 41

Equity Ratios 42

Profitability Ratios 42

Cost Ratios 43

Liquidity Ratios 43

Leverage Ratios 44

Efficiency Ratios 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sanofi

Novo Nordisk A/S

Medtronic plc

Johnson & Johnson

F. Hoffmann-La Roche Ltd.

Eli Lilly and Company

Abbott Laboratories

Ypsomed Holding AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8071
Site License
USD 250 INR 16143
Corporate User License
USD 375 INR 24214

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com